Abstract
Microorganisms are starters of the nascence and subsequent evolution of all biological life varieties on our planet including humans. A contemporary view of a human organism presents it as a superorganism, a dynamic symbiotic community of various prokaryotic and eukaryotic cells (Vakhitov and Sitkin 2014, Shenderov 2008, Shenderov 2014b, Ugolev 1991, Caselli et al. 2011, Dietert and Dietert 2015, Lederberg 2000). The microbial component of this community includes bacteria (which dominate), Eukarya and Archaea (up to 1013–14 cells totally). Microbiome/microbiota (a term introduced into scientific literature by Joshua Lederberg) represents the totality of commensal, symbiotic and pathogenic microorganisms inhabiting human body (Lederberg and McCray 2001). According to the latest data, the human organism contains around 3 × 1013 eukaryotic cells and 3.9 × 1013 microorganisms colonizing human body; it means that quantitatively, the content of human cells and microorganisms is quite similar (Sender et al. 2016). As regards bacterial content, symbiotic microbiota in the digestive tract reaches its maximum in the large intestine (up to 1012 CFU/g); this is the most densely inhabited bio-ecosystem on our planet. Human microbiota has a distinctly individual character on the genus and species levels and — especially — on the strain levels (Gilbert et al. 2016, Meisel and Grice 2017, Mimee et al. 2016, Sonnenburg and Backhed 2016).
All diseases start in the gastrointestinal tract.(Hippocrates 460–370 BC)Multiple and numerous associations of microorganisms inhabiting human gastrointestinal tract determine, to a great extent, our physical and spiritual health.(Mechnikov 1908)Microbes rule the world. We must listen closely to their language and when we learn more, we will be capable of a better and more harmonic interaction with them. The presence of active microbial compounds in the gut has physiological and pathophysiological consequences for the host.(Midtvedt 2008)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Bomba A, Branderburova A, Ricanyova J, Strojny L, Chmelarova A et al. The role of probiotics and natural bioactive compounds in modulation of the common molecular pathways in pathogenesis of atherosclerosis and cancer. Biologia. 2012;67:1–13.
Cani PD Human gut microbiome: hopes, threats and promises. Gut. 2018;67:1716–1725. doi:https://doi.org/10.1136/gutjnl-2018-316723.
Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr. 2011;2:372–376. doi:https://doi.org/10.3945/an.111.000604.
Charbonneau MR, Blanton LV, Di Giulio DB, Relan DA, Lebrilla CB, Mills DA, Gordon JI. A microbial perspective of human developmental biology. Nature. 2016;535:48–55. doi:https://doi.org/10.1038/nature18845.
Dietert RR, Dietert JM. The microbiome and sustainable healthcare. Healthcare. 2015;3:100–129. doi:https://doi.org/10.3390/healthcare3010100.
Gilbert JA, Quinn RA, Debelius J, Morton J, Garg N et al. Microbiome-wide association studies link dynamic microbial consortia to disease. Nature. 2016;535:94–103. doi:https://doi.org/10.1038/nature18850.
Lederberg J, McCray A.T. ‘Ome Sweet’ Omics — a genealogical treasury of words. Scientist. 2001;15(7): 8.
Lederberg J. Infectious history. Science. 2000;288(5464):287–293. doi:https://doi.org/10.1126/science.288.5464.287.
Meisel JC, Grice EA. The human microbiome. Chapter 4. In: Ginsburg G, Willard H, editors. Genomic and Precision Medicine (Third Edition). Elsevier Inc; 2017. p. 63–77. doi:https://doi.org/10.1016/B978-0-12-800681-8.00004-9.
Mimee M, Citorik RJ, Lu TK. Microbiome therapeutics-Advances and challenges. Adv Drug Deliv Rev. 2016;105(Pt A):44–54. doi:https://doi.org/10.1016/j.addr.2016.04.032.
Pflughoeft KJ, Versalovic J. Human microbiome in health and disease. Ann Rev Pathol Mech Dis. 2012;7:99–122. doi:https://doi.org/10.1146/annurev-pathol-011811-132421.
Sender R, Fuchs S, Milo R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell. 2016;164(3):337–340. doi:https://doi.org/10.1016/j.cell.2016.01.013.
Shenderov BA. Functional nutrition and its role in the prevention of metabolic syndrome. Moscow: DeLi print; 2008 (in Russian).
Shenderov BA. Probiotic (symbiotic) bacterial languages. Anaerobe. 2011;17(6):490–495. doi:https://doi.org/10.1016/j.anaerobe.2011.05.009.
Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64. doi:https://doi.org/10.1038/nature18846.
Ugolev AM. Theory of adequate nutrition and trophology. Leningrad: Nauka; 1991. (in Russian).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shenderov, B.A., Sinitsa, A.V., Zakharchenko, M.M., Lang, C. (2020). Introduction. In: METABIOTICS. Springer, Cham. https://doi.org/10.1007/978-3-030-34167-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-34167-1_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-34166-4
Online ISBN: 978-3-030-34167-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)